| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2016 ( Subtotal = -$207,372 ) |
| 2016 | 2014 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01GM098615 | Cadherin-catenin Mediated Contact Inhibition of Cell Growth | 000 | 4 | NIH | 2/1/2016 | -$103,849 |
| 2016 | 2014 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R56AI113095 | Delayed Anaphylaxis to Mammalian Meat caused by IgE Ab to alpha-gal | 001 | 1 | NIH | 4/15/2016 | -$103,523 |
|
| Issue Date FY: 2014 ( Subtotal = $712,994 ) |
| 2014 | 2014 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R56AI113095 | Delayed Anaphylaxis to Mammalian Meat caused by IgE Ab to alpha-gal | 000 | 1 | NIH | 7/18/2014 | $393,523 |
| 2014 | 2014 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01GM098615 | Cadherin-catenin Mediated Contact Inhibition of Cell Growth | 000 | 4 | NIH | 6/23/2014 | $523,606 |
| 2014 | 2013 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01CA136705 | Epigenetic and post-translational regulation of the metastasis suppressor BRMS1 | 002 | 5 | NIH | 9/17/2014 | $373 |
| 2014 | 2013 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01CA136705 | Epigenetic and post-translational regulation of the metastasis suppressor BRMS1 | 000 | 5 | NIH | 1/21/2014 | -$204,508 |
|
| Issue Date FY: 2013 ( Subtotal = $587,407 ) |
| 2013 | 2013 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01GM098615 | Cadherin-catenin Mediated Contact Inhibition of Cell Growth | 000 | 3 | NIH | 7/3/2013 | $505,279 |
| 2013 | 2013 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01CA136705 | Epigenetic and post-translational regulation of the metastasis suppressor BRMS1 | 002 | 5 | NIH | 1/21/2014 | -$204,508 |
| 2013 | 2013 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01CA136705 | Epigenetic and post-translational regulation of the metastasis suppressor BRMS1 | 000 | 5 | NIH | 6/11/2013 | $286,636 |
|
| Issue Date FY: 2012 ( Subtotal = $828,534 ) |
| 2012 | 2012 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01CA136705 | Epigenetic and post-translational regulation of the metastasis suppressor BRMS1 | 000 | 4 | NIH | 5/14/2012 | $304,932 |
| 2012 | 2012 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01GM098615 | Cadherin-catenin Mediated Contact Inhibition of Cell Growth | 000 | 2 | NIH | 7/5/2012 | $523,602 |
|
| Issue Date FY: 2011 ( Subtotal = $828,532 ) |
| 2011 | 2011 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01GM098615 | Cadherin-catenin Mediated Contact Inhibition of Cell Growth | 000 | 1 | NIH | 7/1/2011 | $523,600 |
| 2011 | 2011 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01CA136705 | Epigenetic and post-translational regulation of the metastasis suppressor BRMS1 | 000 | 3 | NIH | 6/30/2011 | $304,932 |
|
| Issue Date FY: 2010 ( Subtotal = $314,363 ) |
| 2010 | 2010 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01CA136705 | Epigenetic and post-translational regulation of the metastasis suppressor BRMS1 | 000 | 2 | NIH | 5/31/2010 | $314,363 |
|
| Issue Date FY: 2009 ( Subtotal = $165,874 ) |
| 2009 | 2009 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01AG026094 | The Sir2-p53-IGF link in mammalian life-span control | 000 | 4 | NIH | 3/25/2009 | $295,537 |
| 2009 | 2009 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01AG026094 | The Sir2-p53-IGF link in mammalian life-span control | 001 | 4 | NIH | 8/31/2009 | -$192,803 |
| 2009 | 2009 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01CA136705 | Epigenetic and post-translational regulation of the metastasis suppressor BRMS1 | 000 | 1 | NIH | 6/19/2009 | $300,684 |
| 2009 | 2008 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | F31AR053373 | MINORITY PREDOCTORAL FELLOWSHIP PROGRAM | 000 | 4 | NIH | 10/13/2008 | -$54,545 |
| 2009 | 2008 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R37DK042191 | CYTOKINES AND INFLAMMATORY BOWEL DISEASE | 000 | 21 | NIH | 4/10/2009 | -$103,206 |
| 2009 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R01DK055812 | Mechanisms of Experimental Crohn's Disease | 000 | 10 | NIH | 4/10/2009 | $0 |
| 2009 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R01DK043701 | Specific Repression of Prolactin Gene Expression | 000 | 14 | NIH | 3/27/2009 | $0 |
| 2009 | 2007 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | U01AI075778 | NEW THERAPEUTICS FOR SHIGA TOXIN-E. COLI DISEASE. | 000 | 1 | NIH | 11/25/2008 | $0 |
| 2009 | 2007 | UNIVERSITY OF VIRGINIA | P.O. BOX 400195 | CHARLOTTESVILLE | VA | 22904-4195 | CHARLOTTESVILLE CITY | USA | R01AG022407 | CYTOCHROME OXIDASE POLYMORPHISMS IN AGING | 000 | 3 | NIH | 12/11/2008 | -$79,793 |
|
| Issue Date FY: 2008 ( Subtotal = $13,928,751 ) (Continued on the next page) |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R33HL088286 | SYSTEMS BIOLOGY OF ANGIOGENESIS: FROM MOLECULES TO THERAPY | 000 | 3 | NIH | 9/16/2008 | $380,741 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R03HD055129 | IMMUNODOMINANT OVARIAN ANTIGENS INVOLVED IN PREMATURE OVARIAN FAILURE | 000 | 2 | NIH | 5/22/2008 | $74,235 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R01AG026094 | The Sir2-p53-IGF link in mammalian life-span control | 000 | 3 | NIH | 2/29/2008 | $295,537 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R03TW007423 | THE ROLE OF NEUROTROPHINS IN ANESTHESIA-INDUCED DEVELOPMENTAL NEUROAPOPTOSIS | 000 | 3 | NIH | 7/26/2008 | $38,230 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R01EB004051 | NOVEL BIODEGRADABLE MATERIALS FOR TISSUE ENGINEERING | 001 | 3 | NIH | 12/31/2007 | $32,569 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R01HD045783 | ANTIMICROBIAL PROTEINS SECRETED BY THE EPIDIDYMIS | 000 | 5 | NIH | 3/6/2008 | $255,070 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | P01HL048807 | STRUCTURAL BIOLOGY OF CARDIOVASCULAR SIGNALING | 000 | 15 | NIH | 3/18/2008 | $1,821,200 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | K01AR051391 | GENETICS OF AUTONTIBODY DIVERSIFICATION | 000 | 5 | NIH | 3/11/2008 | $104,548 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R01GM067222 | MECHANISMS OF ACTIN ASSEMBLY AT MEMBRANES | 000 | 5 | NIH | 2/22/2008 | $244,120 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R01HD034807 | ANALYSIS OF TROPHOBLAST CELL MOTILITY | 000 | 9 | NIH | 3/1/2008 | $41,797 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R01DE015797 | NON-TRADITIONAL SECRETION OF CSH1P IN CANDIDA ALBICANS | 000 | 4 | NIH | 12/7/2007 | $242,756 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R01HL072864 | REGULATION OF THE ENDOTHELIAL CELL GLYCOCALYX | 000 | 5 | NIH | 2/8/2008 | $361,494 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R01NS047378 | FUNCTIONS OF ERK AND P38 MAP KINASES IN ASTROGLIOSIS | 000 | 5 | NIH | 12/7/2007 | $267,506 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R01AI043425 | INHIBITORY SIGNALING VIA FCGRIIB RECEPTOR ON B CELLS | 000 | 10 | NIH | 2/29/2008 | $282,439 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | F31NS059189 | PARVALBUMIN CONTAINING INTERNEURON CONNECTIVITY AND CRITICAL PERIOD MODULATION | 000 | 1 | NIH | 1/25/2008 | $11,450 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | F31AG032138 | BREAST CANCER IN THE CONTEX OF AN ABUSIVE INTIMATE PARTNER IN OLDER WOMEN | 000 | 2 | NIH | 7/30/2008 | $26,345 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | K23DK080133 | MICROVASCULAR INFLAMMATION AND INSULIN ACTION IN HUMAN MUSCLE | 000 | 1 | NIH | 8/12/2008 | $0 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R03MH085680 | HIGH THROUGHPUT SCREEN FOR INHIBITORS OF INFLUENZA NS1 PROTEIN FUNCTION | 000 | 1 | NIH | 9/25/2008 | $24,999 |
| 2008 | 2008 | UNIVERSITY OF VIRGINIA | PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | CHARLOTTESVILLE CITY | USA | R21DK077372 | GROWTH HORMONE SECRETAGOGUE MK-677 THERAPY IN CKD AND ESRD | 000 | 2 | NIH | 7/10/2008 | $222,705 |
|